Shares of CME Group Inc. CME have gained 15.5% previously 12 months, outperforming the trade‘s progress of 8.1%.
CME Group has outperformed its friends, together with Intercontinental Change Inc. ICE, S&P International Inc. SPGI and OTC Markets Group Inc. OTCM. Shares of ICE and SPGI have gained 7.5% and 4.1%, respectively, whereas OTCM inventory has misplaced 4.4% previously 12 months.
Picture Supply: Zacks Funding Analysis
With a market capitalization of $98.71 billion, the typical quantity of shares traded within the final three months was 1.9 million. CME has a stable observe file of beating earnings estimates in every of the final 4 quarters, with a median of 1.82%.
CME Shares are Undervalued
CME Group shares are buying and selling at a reduction to the Zacks Securities and Change trade. Its ahead price-to-earnings of 23.61X is decrease than the trade common of 23.83X.
Picture Supply: Zacks Funding Analysis
CME Buying and selling Above 50-Day and 200-Day Shifting Averages
Shares of CME Group closed at $273.74 on Wednesday and are buying and selling above the 50-day and 200-day easy transferring averages (SMA) of $271.90 and $270.71, respectively, indicating stable upward momentum. SMA is a extensively used technical evaluation software to foretell future value tendencies by analyzing historic value information.
Picture Supply: Zacks Funding Analysis
CME’s Progress Projection
The Zacks Consensus Estimate for CME Group’s 2025 earnings per share (EPS) signifies an 8.4% year-over-year improve. The consensus estimate for revenues is pegged at $6.53 billion, implying a year-over-year enchancment of 6.5%.
The consensus estimate for 2026 EPS and revenues signifies a rise of 4.3% and 4.9%, respectively, from the corresponding 2025 estimates.
Optimistic Analyst Sentiment for CME
Two of the ten analysts masking the inventory have raised estimates for 2025, and two analysts have raised the identical for 2026 over the previous 30 days. Thus, the Zacks Consensus Estimate for 2025 and 2026 earnings has moved north 0.08% and 0.3%, respectively, previously 30 days.
Goal Worth Displays Potential Upside
Based mostly on short-term value targets supplied by 16 analysts, the Zacks common value goal is $291.38 per share. The typical signifies a possible 6.4% upside from the final closing value.
Picture Supply: Zacks Funding Analysis
Elements Impacting CME
CME Group demonstrates sturdy natural progress. Provided that CME is an trade, it naturally advantages from heightened market volatility, which fuels buying and selling exercise and, in flip, will increase clearing and transaction charges. These charges proceed to be the most important contributor to CME’s prime line, and their sustained progress bodes properly for future income growth.
CME Group can also be seeing rising digital buying and selling exercise and growing traction in crypto belongings, pushed by rising participation within the broader crypto economic system. With Donald Trump’s second time period ushering in a extra crypto-friendly regulatory local weather, CME is well-positioned to capitalize on these tendencies.
CME’s investments are delivering optimistic returns, and its ongoing deal with value effectivity helps to enhance margins. A sturdy capital base helps initiatives to develop its market information enterprise, broaden its product vary and pursue strategic capital deployment.
Furthermore, CME has persistently delivered sturdy monetary efficiency, with free money circulation conversion exceeding 85% in latest quarters — a testomony to its stable earnings high quality.
Finish Notes
A powerful international presence, a compelling product portfolio, a stable capital place and a deal with over-the-counter clearing companies poise CME properly for progress. A crypto-friendly regulatory local weather will add to the upside.
CME’s dividend historical past is spectacular, too. It pays 5 dividends per 12 months, with the fifth being variable and primarily based on extra money circulation, making it a beautiful decide for yield-seeking buyers.
Its stable progress projection, engaging valuation, and optimistic analyst assertion are different positives. The inventory at the moment carries a Zacks Rank #3 (Maintain). You possibly can see the whole record of right this moment’s Zacks #1 Rank (Sturdy Purchase) shares right here.
Zacks Naming High 10 Shares for 2026
Need to be tipped off early to our 10 prime picks for everything of 2026? Historical past suggests their efficiency may very well be sensational.
From 2012 (when our Director of Analysis Sheraz Mian assumed duty for the portfolio) by way of November, 2025, the Zacks High 10 Shares gained +2,530.8%, greater than QUADRUPLING the S&P 500’s +570.3%.
Now Sheraz is combing by way of 4,400 corporations to handpick the most effective 10 tickers to purchase and maintain in 2026. Don’t miss your probability to get in on these shares once they’re launched on January 5.
Be First to New High 10 Shares >>
Intercontinental Change Inc. (ICE) : Free Inventory Evaluation Report
CME Group Inc. (CME) : Free Inventory Evaluation Report
OTC Markets Group Inc. (OTCM) : Free Inventory Evaluation Report
S&P International Inc. (SPGI) : Free Inventory Evaluation Report
This text initially revealed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.
